PHACS in the News
See below for selected press coverage of PHACS' work.
2023
NICHD World AIDS Day Spotlight: Reflecting on Recent Progress in HIV Research (PHACS papers highlighted) (December 1, 2023, NICHD)
NICHD Maternal and Pediatric Infectious Disease Branch World AIDS Day News (PHACS paper highlighted) (December 1, 2023, NICHD)
Science Update: NIH-funded study finds several potential risk factors for high blood pressure disorders of pregnancy in people with HIV (September 27, 2023, NICHD)
Sonia Lee (Chief of Maternal and Pediatric Infectious Disease Branch at NICHD) Receives HHS Secretary's Commendation (September 2023, NICHD)
Increasing social support for young adults with HIV could improve viral suppression (July 19, 2023, Pharmacy Times)
Social support promotes HIV suppression among young adults, NIH-funded study suggests (July 17, 2023, National Institute for Child Health and Human Development)
Social support may help young adults living with HIV maintain viral suppression (June 26, 2023, Harvard T.H. Chan School of Public Health)
Analyzing pregnant women with HIV for APOs and pro-inflammatory fatty acid signatures (April 27, 2023, Physician's Weekly)
HIV medication during pregnancy may cause developmental delays in children: Study (April 18, 2023, Medical Daily)
Kids whose moms took HIV meds while pregnant may be at higher risk for developmental delays (April 17, 2023, Health Day)
Risk of developmental delays may be higher for HIV-free children whose mothers began antiretroviral treatment during pregnancy, NIH-funded study suggests (March 27, 2023, NICHD News)
2022
Dolutegravir: A better choice for HIV viral suppression in pregnancy? (November 14, 2022, MiMS Pharmacy)
Dolutegravir effectively suppresses HIV in pregnant women (November 2, 2022, Contagion Live)
Better viral suppression with dolutegravir than other antiretrovirals in pregnancy, but not all guidelines recommend it (September 20, 2022, AIDSMap)
Dolutegravir offers superior HIV suppression in pregnant women (September 14, 2022, Contagion Live)
Study offers reassurance that dolutegravir-based ART during pregnancy is effective, safe (September 6, 2022, Healio)
First-line HIV treatment proves mettle in pregnant patients (September 1, 2022, MedPage Today)
Dolutegravir-based antiretroviral therapies for HIV-1 effective in pregnancy (September 1, 2022, Harvard T.H. Chan School of Public Health)
2021
Tracking emotional and behavioral issues in youth born to women with HIV (July 22, 2021, Harvard T.H. Chan School of Public Health)
2020
Trends in postpartum viral load among women living with perinatal HIV infection in the USA: A prospective cohort study (March 10, 2020, MDLinx)
Discordance between ART prescribing practices and guidelines in pregnant women (January 13, 2020, Infectious Disease Advisor)
Are pregnant women getting the right HIV antiretrovirals? (January 10, 2020, ContagionLive)
2019
Exposure to HIV drug in the womb may increase risk of microcephaly (December 11, 2019, Harvard T.H. Chan School of Public Health)
HIV drug exposure in womb may increase child risk of microcephaly, developmental delays (November 18, 2019, Science Daily)
Exposure to HIV drug in the womb may increase risk of microcephaly, developmental delays in children (November 17, 2019, American Pharmacists Association)
Exposure to HIV drug in the womb may increase risk of microcephaly, developmental delays in children (November 18, 2019, National Institutes of Health)
Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): A prospective cohort study (November 15, 2019, The Lancet HIV)
Social support, HIV self-management improve transition from pediatric to adult care (October 2019, Infectious Diseases in Children)
HIV-exposed, uninfected kids hospitalized at twice the rate of unexposed kids (September 4, 2019, Healio)
Major challenges in care transitions for young adults with perinatally acquired HIV (August 30, 2019, Healio)
Social support, HIV self-management improve transition from pediatric to adult care (August 28, 2019, NEJM Journal Watch)
Kids born with HIV find difficulty taking their medication as they grow older (August 21, 2019, Health24)
Youth born with HIV face unique challenges (August 15, 2019, ContagionLive)
For kids born with HIV, taking needed meds gets harder with age: study (August 14, 2019, Cascade Mental Health)
For children born with HIV, taking needed meds gets harder with age: study (August 14, 2019, HealthDay)
For children born with HIV, taking needed meds gets harder with age: study (August 14, 2019, U.S. News)
As kids born with HIV grow up, adherence to treatment gets hard (August 9, 2019, Poz)
Harvard: For children born with HIV, adhering to medications gets harder with age (August 8, 2019, Association of Schools and Programs of Public Health)
For children born with HIV, adhering to medication gets harder with age (August 8, 2019, Outrage Magazine)
For children born with HIV, medication adherence, viral suppression decreases with age (August 6, 2019, AJMC)
Compliance with meds falters with age in youth born with HIV (August 2, 2019, Physicians Weekly)
For children born with HIV, adhering to medication gets harder with age (July 31, 2019, Science Daily)
For children born with HIV, adhering to medication gets harder with age (July 31, 2019, Harvard T.H. Chan School of Public Health)
Clinical research update (July 16, 2019, American Academy of HIV Medicine)
2018
Cardiac effects of HIV antiretrovirals vary in HIV-infected children (October 25, 2018, MD Magazine)
Efavirenz, but not dolutegravir, linked to neurological problems in children (October 11, 2018, AIDSMap)
Antiretroviral therapy during pregnancy can increase risk of childhood neurologic abnormalities (October 9, 2018, DG News)
HIV and ID Observations Blog Post (October 8, 2018, NEJM Journal Watch)
Protease inhibitor use during first trimester associated with higher risk for preterm birth (October 7, 2018, Healio)
Efavirenz in pregnancy tied to neurologic risk in children (October 5, 2018, Medscape)
Study: In Utero antiretroviral exposure possibly linked to neurologic outcomes (October 4, 2018, Pharmacy Times)
Efavirenz exposure increases risk of neurologic conditions in infants (October 4, 2018, Healio)
Differences in the mouths of youth born with HIV may increase their risk of dental decay (July 10, 2018, EurekAlert)
The Forsyth Institute discovers that differences in the oral microbiome of youth born with HIV may increase their risk of dental decay (July 10, 2018, Forsyth Institute)
Higher rate of mother-to-child transmission among women with perinatal HIV (June 13, 2018, Infectious Disease Advisor)
Risk of adverse birth outcomes in women with HIV using tenofovir-emtricitabine (May 11, 2018, Infectious Disease Advisor)
ART with tenofovir backbone not linked to worse outcomes (May 2, 2018, MDLinx Infectious Disease)
Tenofovir and FTC does not increase preterm birth and early infant death (May 2, 2018, Medical Brief: Africa's Medical Media Digest)
In utero exposure to tenofovir-emtricitabine not associated with higher risk of advere birth outcomes (May 1, 2018, 2 Minute Medicine)
NIH-funded study finds anti-HIV drug combination does not increase preterm birth risk (April 27, 2018, Pharmabiz)
HIV-Therapie: Neue Daten bei Schwangeren (April 27, 2018, Pharmazeutische Zeitung)
ART regimens containing tenofovir appear not to increase birth risks (April 27, 2018, Healio)
Antiretroviral choice for pregnant women with HIV does not appear to impact birth outcomes (April 26, 2018, Family Practice News)
Risk of adverse pregnancy outcomes with TDF-FTC-ATV/r similar or lower than other ART regimens (April 26, 2018, ContagionLive)
Anti-HIV drug combination does not increase preterm birth risk, study suggests (April 25, 2018, AIDS Info)
Risk of adverse birth outcomes no higher with TDF-FTC-LPV/r (April 25, 2018, Physician's Weekly)
No higher risk for adverse birth outcomes with 3-drug HIV Tx (April 25, 2018, MedPage Today)
Risk of adverse birth outcomes no higher with TDF-FTC-LPV/r (April 25, 2018, DoctorsLounge)
Risk to babies of mothers with HIV from three antiretroviral regimens appears to be low (April 25, 2018, Harvard T.H. Chan School of Public Health)
Anti-HIV drug combination does not increase preterm birth risk, study suggests (April 25, 2018, National Institutes of Health)
Video: Vail Film Fest Look Live: Faces of PHACS (April 8, 2018, TV8 Vail)
Final day of Vail Film Festival honors filmmakers and their art (April 7, 2018, Castle Rock News Press)
Vail Film Festival kicks off with celebration of women filmmakers (April 6, 2018, Centennial Citizen)
Pediatric HIV/AIDS Cohort Festival plays Vail Film Festival (April 4, 2018, Harvard T.H. Chan School of Public Health)
Vail Film Festival announces 2018 lineup celebrating female filmmakers (March 6, 2018, Vail Daily)
2017
Asthma may be over diagnosed in children born with HIV (October 19, 2017, Harvard T.H. Chan School of Public Health)
Asthma might be over diagnosed in children born with HIV (October 5, 2017, Baylor College of Medicine)
Improving long-term outcomes in perinatally infected youth with HIV (April 28, 2017, Infectious Disease Advisor)
Statisticians lend critical expertise to infectious disease research (April 27, 2017, Harvard T. H. Chan School of Public Health)
Adhering to treatment during adolescence keeps HIV-positive youth on healthier track (April 3, 2017, Harvard T. H. Chan School of Public Health)
Adolescents perinatally infected with HIV are at increased risk of serious physical and mental health problems (March 28, 2017, MedicalResearch.com)
Health problems may increase as adolescents, young adults infected with HIV at birth get older (March 27, 2017, Massachusetts General Hospital)
2016
HIV disclosure comics on the Graphic Medicine Podcast (August 26, 2016, Graphic Medicine Podcast)
How violence could be hurting kids with HIV (August 25, 2016, Washington Post)
Among youth born with HIV, those recently exposed to violence may have poorer clinical outcomes (August 22, 2016, Harvard T. H. Chan School of Public Health)
HIV and hearing loss (February 3, 2016, American Academy of Audiology)
2015
Monitoring the safety of ARV therapy during pregnancy (December 1, 2015, Harvard T. H. Chan School of Public Health)
Two doses of chickenpox vaccine confer long-term protection in children on anti-HIV therapy (October 28, 2015, National Institutes of Health)
Drug used to treat HIV linked to lower bone mass in newborns (September 30, 2015, National Institutes of Health)
MMR vaccination may not be reliable in HIV+ children (August 15, 2015, MedicalResearch.com)
Vaccines didn't work for thousands of teens born with HIV (August 14, 2015, Buzzfeed)
Study: Thousands of vaccinated teens born with HIV aren't protected from measles (August 14, 2015, Slate)
Large percentage of youth with HIV may lack immunity to measles, mumps, and rubella (August 13, 2015, National Institutes of Health)
For most children with with HIV and low immune cell count, cells rebound after treatment
(March 23, 2015, National Institutes of Health)
Study reaffirms safety of Anti-HIV Drugs During Pregnancy (January 27, 2015, Eunice Kennedy Shriver National Institute of Child Health and Human Development)
Substance Use Drops Sharply in Pregnant US Women with HIV (January 20, 2015, International AIDS Society)
2014
Harvard Study Gives Reassurance for Pregnant Women with HIV (November 11, 2014, Boston Globe)
Overall Risk of Birth Defects Appears Low for Women Taking Antiretrovirals During Early Pregnancy (November 10, 2014, Harvard T. H. Chan School of Public Health)
Younger Age at ART Initiation Led to Longer Viral Suppression (October 17, 2014, Healio)
Children Found at Higher Drug-Resistance Risk (June 3, 2014, Suncoast News)
HIV-positive Children More Likely to Develop Drug Resistance
(May 22, 2014, Tulane University)
One third of US HIV+ mothers have psychiatric or substance disorders (March 29, 2014, International AIDS Society)
(Video) CROI 2014: Newborns Exposed to Tenofovir Have Lower Bone Content (March 18, 2014, HIVandHepatitis.com)
Adolescents born with HIV at increased risk for CVD (March 10, 2014, Cardiology Today)
Heart problems linked to those born with HIV (March 3, 2014, New York Times)
Kids born with HIV might have higher risk of heart disease (March 1, 2014, ZipTrials)
Kids born with HIV may face heart risks later, study suggests (February 27, 2014, Philadelphia Inquirer Online)
Youth born with HIV may have higher heart disease risk, NIH network study shows (February 24, 2014, National Institutes of Health)
Youth born with HIV appear at higher risk for heart disease (February 24, 2014, Harvard T. H. Chan School of Public Health)
2013
HIV-infected children may be protected against puberty delays by newer drugs (October 15, 2013, Harvard T. H. Chan School of Public Health)
Anti-HIV drugs may protect against puberty delays in HIV-infected children (August 15, 2013, National Institutes of Health)
Prenatal anti-HIV meds not linked to childrens' language delays (August 14, 2013, Science Daily)
Anti-HIV drugs in pregnancy not linked to children's language delays (July 18, 2013, National Institutes of Health)
2012
Interventions recommended to promote healthy behaviors among perinatally HIV-infected youth (November 8, 2012, Harvard T. H. Chan School of Public Health)
Interventions needed to promote healthy behaviors among perinatally HIV-infected youth (November 8, 2012, Clinical Infectious Diseases)
Interventions needed to promote healthy behaviors among perinatally HIV-infected youth (November 8, 2012, Science Daily)
Intervention strategies are needed for HIV-positive teens (November 8, 2012, Healthline)
HSPH research pinpoints strategy for monitoring antiretrovirals' effect on children of HIV-infected mothers (July 30, 2012, Harvard T. H. Chan School of Public Health)
2011
Tracking the long-term effects of lifesaving drugs (Spring/Summer Issue, Harvard Public Health Review)
2009
5% or more of perinatally HIV-infected adolescents may be long-term nonprogressors, U.S. study suggests (February 10, 2009, TheBody.com)